66 research outputs found

    Cardiopulmonary Resuscitation–attitudes and awareness among physical therapists of Karachi–A Cross-sectional Survey

    Get PDF
    Background: The prime objective of CPR is to maintain enough circulation to preserve existence till specialized treatment is provided. As mentioned, early CPR is an essential aspect in the chain of survival in Emergency Cardiovascular Care (ECC). Objective: To compare and study the attitude and awareness level related to Cardiopulmonary Resuscitation (CPR) among physical therapists in Karachi. Methods: The total sample was 126 physical therapists in this study. This was an observational study based on a cross-sectional design conducted for the assessment of CPR attitude and awareness of physical therapists through simple convenient sampling technique during the period of December 2020 to June 2021 from various public and private sector hospitals and rehabilitation centers of Karachi. Data collection was done through a questionnaire consisting 31 questions categorized into three sections including demographics, CPR attitudes and CPR awareness. Results: Results revealed more female physical therapists (76%). Most of them (70%) were aged less than 35 years and had less than 15 years of working experience. Most of them were engaged in musculoskeletal practice (40.5%). Almost 31% participants had CPR certifications. Less than half of the physical therapists (38.9%) reported ≤ 25% success rate of CPR. Majority of the participants stated that their ability to perform CPR was satisfactory (44.4%). Conclusion: The overall awareness of physical therapists regarding CPR was evident, but the attitude regarding CPR need improvement. It was also evident from the results that mandatory professional training programs should be conducted.   Keywords: Attitude, Awareness, Cardiac Arrest, Cardiopulmonary Resuscitation (CPR), Physical Therapist

    A novel gabapentin analogue assuages neuropathic pain response in chronic sciatic nerve constriction model in rats

    Get PDF
    Gabapentin (GBP) is an established drug that has been used in the management of symptoms of neuropathy but it is associated with unwanted side effects such as sedation and motor incoordination. The goal of the study was to find out a drug with greater efficacy and safety for the treatment of neuropathic pain. Our previously synthesized GABA analogue (Gabapentsal, GPS) was tested (25-100 mg/kg, i.p) in chronic constriction injury (CCI) induced nociceptive model of static allodynia, dynamic allodynia, thermal hyperalgesia, mechanical hyperalgesia and cold allodynia in rats (Sprague Dawley). Open field and rotarod tests were performed to assess the impact of GPS on the motor performance of the animals. GBP (100 mg/kg, i.p) was used as a standard for comparison. GPS dose dependently reduced static (P <0.001) and dynamic allodynia (P <0.001), thermal hyperalgesia (P <0.001), mechanical hyperalgesia (P < 0.001) and cold allodynia (P < 0.001). In comparison to GBP, GPS failed to alter any significantly the motor performance of rats in both the open field and rotarod assays. These results suggest that GPS is effective in alleviating nociception in CCI neuropathic pain model but free from the side effect of motor discoordination seen in the treatment with GBP. In conclusion, GPS may prove to be a prospectively more effective and safer option in the management of neuropathic syndromes

    Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial

    Get PDF
    Background: Tranexamic acid reduces surgical bleeding and reduces death due to bleeding in patients with trauma. Meta-analyses of small trials show that tranexamic acid might decrease deaths from gastrointestinal bleeding. We aimed to assess the effects of tranexamic acid in patients with gastrointestinal bleeding. Methods: We did an international, multicentre, randomised, placebo-controlled trial in 164 hospitals in 15 countries. Patients were enrolled if the responsible clinician was uncertain whether to use tranexamic acid, were aged above the minimum age considered an adult in their country (either aged 16 years and older or aged 18 years and older), and had significant (defined as at risk of bleeding to death) upper or lower gastrointestinal bleeding. Patients were randomly assigned by selection of a numbered treatment pack from a box containing eight packs that were identical apart from the pack number. Patients received either a loading dose of 1 g tranexamic acid, which was added to 100 mL infusion bag of 0·9% sodium chloride and infused by slow intravenous injection over 10 min, followed by a maintenance dose of 3 g tranexamic acid added to 1 L of any isotonic intravenous solution and infused at 125 mg/h for 24 h, or placebo (sodium chloride 0·9%). Patients, caregivers, and those assessing outcomes were masked to allocation. The primary outcome was death due to bleeding within 5 days of randomisation; analysis excluded patients who received neither dose of the allocated treatment and those for whom outcome data on death were unavailable. This trial was registered with Current Controlled Trials, ISRCTN11225767, and ClinicalTrials.gov, NCT01658124. Findings: Between July 4, 2013, and June 21, 2019, we randomly allocated 12 009 patients to receive tranexamic acid (5994, 49·9%) or matching placebo (6015, 50·1%), of whom 11 952 (99·5%) received the first dose of the allocated treatment. Death due to bleeding within 5 days of randomisation occurred in 222 (4%) of 5956 patients in the tranexamic acid group and in 226 (4%) of 5981 patients in the placebo group (risk ratio [RR] 0·99, 95% CI 0·82–1·18). Arterial thromboembolic events (myocardial infarction or stroke) were similar in the tranexamic acid group and placebo group (42 [0·7%] of 5952 vs 46 [0·8%] of 5977; 0·92; 0·60 to 1·39). Venous thromboembolic events (deep vein thrombosis or pulmonary embolism) were higher in tranexamic acid group than in the placebo group (48 [0·8%] of 5952 vs 26 [0·4%] of 5977; RR 1·85; 95% CI 1·15 to 2·98). Interpretation: We found that tranexamic acid did not reduce death from gastrointestinal bleeding. On the basis of our results, tranexamic acid should not be used for the treatment of gastrointestinal bleeding outside the context of a randomised trial

    Burnout among surgeons before and during the SARS-CoV-2 pandemic: an international survey

    Get PDF
    Background: SARS-CoV-2 pandemic has had many significant impacts within the surgical realm, and surgeons have been obligated to reconsider almost every aspect of daily clinical practice. Methods: This is a cross-sectional study reported in compliance with the CHERRIES guidelines and conducted through an online platform from June 14th to July 15th, 2020. The primary outcome was the burden of burnout during the pandemic indicated by the validated Shirom-Melamed Burnout Measure. Results: Nine hundred fifty-four surgeons completed the survey. The median length of practice was 10&nbsp;years; 78.2% included were male with a median age of 37&nbsp;years old, 39.5% were consultants, 68.9% were general surgeons, and 55.7% were affiliated with an academic institution. Overall, there was a significant increase in the mean burnout score during the pandemic; longer years of practice and older age were significantly associated with less burnout. There were significant reductions in the median number of outpatient visits, operated cases, on-call hours, emergency visits, and research work, so, 48.2% of respondents felt that the training resources were insufficient. The majority (81.3%) of respondents reported that their hospitals were included in the management of COVID-19, 66.5% felt their roles had been minimized; 41% were asked to assist in non-surgical medical practices, and 37.6% of respondents were included in COVID-19 management. Conclusions: There was a significant burnout among trainees. Almost all aspects of clinical and research activities were affected with a significant reduction in the volume of research, outpatient clinic visits, surgical procedures, on-call hours, and emergency cases hindering the training. Trial registration: The study was registered on clicaltrials.gov "NCT04433286" on 16/06/2020

    Comparison of blood loss between intra-articular and intra-venous administration of tranexamic acid in primary total knee arthroplasty

    No full text
    Objective: To compare the blood loss between intra-articular and intra-venous administration of tranexamic acid (TXA) in patients undergoing primary total knee arthroplasty. Design of study: It was a randomized controlled trial. Study duration and settings: This study was carried out at the Orthopedic Departments of Combined Military Hospital Lahore and Rawalpindi from Jan 2016 to March 2018. Methodology: Patients of both the genders were involved this study who had age in the rage of 40–80 years undergoing primary unilateral total knee arthroplasty for degenerative conditions like osteoarthritis and rheumatoid arthritis. These patients were randomly divided into two treatment groups. Patients in IA group received intra-articular tranexamic acid while those in IV group received intravenous tranexamic acid. From all the patients, a written signed consent was taken. Findings: Females were predominant with male-to-female ratio of 1:3.7. The mean age of the patients was 67.3 ± 8.2 years while the mean BMI was 30.9 ± 2.9 Kg/m2. Majority (n = 191, 95.5%) of the patients had osteoarthritis while remaining 9 (4.5%) patients had rheumatoid arthritis. There was no statistically significant difference between intra-articular and intra-venous administration of tranexamic acid in terms of mean post-operative hemoglobin (9.93 ± 1.14 vs. 9.87 ± 1.26 g/dL; p-value = 0.724), mean post-operative hematocrit (34.8 ± 1.66 vs. 34.73 ± 1.27%; p-value = 0.594), and mean fall in hemoglobin (2.27 ± 0.34 vs. 2.25 ± 0.30 g/dL; p-value = 0.587) and hematocrit (2.34 ± 0.94 vs. 2.46 ± 0.28%; p-value = 0.216). Conclusion: Intra-articular administration of tranexamic acid was found to be as effective and safe as intra-venous administration in reducing blood loss in primary total knee arthroplasty. Due to convenience, the use of intra-articular administration of tranexamic acid after primary TKA may be considered in future practice

    Prunus Avium L.; Phytochemistry, Nutritional and Pharmacological Review

    Get PDF
    Current studies were made to investigate the phytochemistry, nutritional and pharmacological studies on Prunus Avium L. (sweet cherry or wild cherry). The plant is a rich source of many phytochemicals, nutrients, phenolic compounds, sugars, anthocyanins, perillyl and phenolics. The presence of chemical compounds such as cyanidin 3-sophoroside, cyanidin 3-rutinoside, cyanidin 3-glucosylrutinoside, cyanidin 3-glucoside etc. renders the cherry fruit to demonstrate anti-cancer and anti-oxidation potential, antigenotoxic, anti-inflammatory, cytotoxic, antimicrobial, neuroprotective and diuretic activities. Cherry consists of cyanogenic glucoside (prunasin) which assists the body in tranquilizing cough and also effective for nervous touchiness and nervous dyspepsia. For secure treatment of cough, pharmaceutical companies isolate prussic acid from the cherry bark as a dynamic component. Wild cherry is also helpful in treatment of arthritis due to the presence of anthocyanins.Keywords: Sweet cherry; Phytochemicals; Nutrients; Antioxidants; Pharmaceutica

    Effect of Elevated Temperatures on Mortar with Naturally Occurring Volcanic Ash and Its Blend with Electric Arc Furnace Slag

    No full text
    The mechanical behavior of basaltic volcanic ash (VA) and fly ash (FA) as a cement replacement under elevated temperatures is mainly investigated in the current study. For this, cement content has been partially replaced with and without the presence of electric arc furnace slag (S). Four distinct ranges of temperatures (200°C, 400°C, 600°C, and 800°C) were selected, and the modified mixes were subjected to these gradually elevated temperatures. Samples were cured and cooled by using air- and water-cooling techniques. Test results were established by examining the sample weights and compressive strength before and after the exposure of each temperature level. The pozzolanic potential of volcanic ash and fly ash samples was identified using the strength activity index. After analyzing the test results, it has been found that there is a significant effect on the compressive strength of mortar mixes at the early ages of its strength gain. However, at the later ages of curing, samples modified with volcanic and fly ash with the presence of electric arc furnace slag have shown a better performance than control mix in terms of strength and weight loss
    corecore